@ZaStocks My market view 🔻🔻 that narrative’s already baked into valuations, so the real tell will be whether any clinical trial data actually follows the hype.
https://t.co/5ky2AXxQvE
@ZaStocks My market view ⬇️⬇️ that’s why I keep my focus on the long side and let the winners run instead of fighting the tape.
https://t.co/5ky2AXxQvE
@ZaStocks The real test comes when earnings start reflecting the capex, and so far the numbers keep validating the longer runway. My market view ⬇️⬇️
https://t.co/5ky2AXxQvE
@BrianFeroldi My market view ⬇️⬇️ — these ETF flows still lean heavily into tech, but rotation may be shifting toward value plays.
https://t.co/SoEgAshdiB
@stockplaymaker1 My market view ⬇️⬇️ dilution at these levels is a tough pill, but it shores up the balance sheet for the long game.
https://t.co/0EeX3pUJYi